Your session is about to expire
← Back to Search
Drug: Bupivacaine 0.375% 20 mL for Acute Pain
Study Summary
This trial looks at whether the amount of local anesthetic injected during a quadratus lumborum block is more important than the concentration of the anesthetic in terms of pain control and opioid consumption after surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research endeavor presently open to participants?
"This medical study has been accepting participants since April 1st 2021, according to the records hosted on clinicaltrials.gov. The trial was last modified on March 29th 2022."
Has the FDA sanctioned Bupivacaine 0.375% 20 mL for clinical use?
"Our team's assessment of the safety of Drug: Bupivacaine 0.375% 20 mL was a 3, due to its Phase 4 status and subsequent authorization for use by regulatory bodies."
Is the eligibility criterion of this experiment limited to those under 40 years old?
"For this research, individuals aged 18 and above but below the age of 90 are eligible for enrollment."
To what maladies is the medication Bupivacaine 0.375% 20 mL typically administered?
"Drug: Bupivacaine 0.375% 20 mL can be implemented to treat permphigus, acute nonspecific tenosynovitis, and general anesthesia."
What findings have been reported from previous investigations utilizing Bupivacaine 0.375% 20 mL?
"Currently, 18 Phase 3 trials of Drug: Bupivacaine 0.375% 20 mL are active with a total of 109 studies being conducted. Although there are numerous Philadelphia locations where this drug is tested, the scope extends to 144 sites throughout the country."
Is there a way for me to participate in this trial?
"This trial seeks to enroll 60 patients between ages 18 and 90 with acute pain. In order to qualify, they must be aged between 18-80 years old, have a body mass index (BMI) of 19-45 or larger than 50 kgs, identify as male or female regardless of race, possess an American Society of Anesthesiologists physical status classification I-III and receive spinal anesthesia."
What is the aggregate sum of individuals taking part in this investigation?
"Affirmative. Data hosted on clinicaltrials.gov verifies this medical trial is actively seeking out participants; the initial posting was made April 1st 2021 and a subsequent update occurred March 29th 2022. Two sites are looking to enroll 60 individuals in total between them."
Share this study with friends
Copy Link
Messenger